• Citing Article List

    The journal uses Crossref Cited-by service counts times cited of published articles. Cited-by allows Crossref members to find out who is citing their content. This is the Citing Article List of “High avidity of vaccine-induced immunoglobulin G against SARS-CoV-2: potential relevance for protective humoral immunity”.
    No. Publication Date Citing Article
    1 2022 Georg Bauer, Friedhelm Struck, Eva Staschik, Julia Maile, Karin Wochinz‐Richter, Manfred Motz, Erwin Soutschek. Differential avidity determination of IgG directed towards the receptor‐binding domain (RBD) of SARS‐CoV‐2 wild‐type and its variants in one assay: Rational tool for the assessment of protective immunity, Journal of Medical Virology. 2022; 94: 5294.  https://doi.org/10.1002/jmv.28006
    2 2023 Amanda Izeli Portilho, Elizabeth De Gaspari. 2023;   https://doi.org/10.5772/intechopen.107908
    3 2023 Hernan H. M. da Costa, Monica Bielavsky, Diego J. B. Orts, Sergio Araujo, Patrícia P. Adriani, Juliana S. Nogueira, Renato M. Astray, Ramendra P. Pandey, Marcelo Lancellotti, Jair P. Cunha-Junior, Carlos R. Prudencio. Production of Recombinant Zika Virus Envelope Protein by Airlift Bioreactor as a New Subunit Vaccine Platform, International Journal of Molecular Sciences. 2023; 24: 13955.  https://doi.org/10.3390/ijms241813955
    4 2022 Amanda Izeli Portilho, Gabrielle Gimenes Lima, Elizabeth De Gaspari. SARS-CoV-2 vaccines: Potential refinements through induction of mucosal and trained immunity, Clinics. 2022; 77: 100057100057.  https://doi.org/10.1016/j.clinsp.2022.100057
    5 2022 Jonathon M. Monroe, Iana H. Haralambieva, Nathaniel D. Warner, Diane E. Grill, Huy Quang Quach, Richard B. Kennedy. Longitudinal antibody titer, avidity, and neutralizing responses after SARS-CoV-2 infection, Heliyon. 2022; 8: e11676e11676.  https://doi.org/10.1016/j.heliyon.2022.e11676
    6 2024 Amanda Izeli Portilho, Hernan Hermes Monteiro da Costa, Marcia Grando Guereschi, Carlos Roberto Prudencio, Elizabeth De Gaspari. Hybrid response to SARS-CoV-2 and Neisseria meningitidis C after an OMV-adjuvanted immunization in mice and their offspring , Human Vaccines & Immunotherapeutics. 2024; 20: 2346963.  https://doi.org/10.1080/21645515.2024.2346963
    7 2023 Etsuhisa Takahashi, Takako Sawabuchi, Tetsuya Homma, Yosuke Fukuda, Hironori Sagara, Takeshi Kinjo, Kaori Fujita, Shigeru Suga, Takashi Kimoto, Satoko Sakai, Keiko Kameda, Hiroshi Kido. Clinical Utility of SARS-CoV-2 Antibody Titer Multiplied by Binding Avidity of Receptor-Binding Domain (RBD) in Monitoring Protective Immunity and Clinical Severity, Viruses. 2023; 15: 1662.  https://doi.org/10.3390/v15081662
    8 2023 Hernan H. M. da Costa, Diego J. B. Orts, Andrew D. Moura, Amaro N. Duarte-Neto, Cinthya S. Cirqueira, Rodrigo A. Réssio, Cristina T. Kanamura, Karen Miguita, Jerenice E. Ferreira, Raimunda T. M. Santos, Patricia P. Adriani, Jair P. Cunha-Junior, Renato M. Astray, Regina M. Catarino, Marcelo Lancelotti, Carlos R. Prudencio. RBD and Spike DNA-Based Immunization in Rabbits Elicited IgG Avidity Maturation and High Neutralizing Antibody Responses against SARS-CoV-2, Viruses. 2023; 15: 555.  https://doi.org/10.3390/v15020555